Find a Clinical Trial

The American Lung Association recommends considering clinical trials as soon as you are diagnosed, and every time you must make a treatment decision. Clinical trials are carefully monitored scientific research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease.


A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat with Pembro and CTX Versus Placebo with Pembro and CTX in 1L, Metastatic KEAP1/NRF2-Mutated, Nonsquamous NSCLC


To test the efficacy and safety of TTFields, using the NovoTTF-100L system, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment.

Lung Cancer Study

This is a research study that is aimed at finding the location of gene(s) that may increase the risk of lung cancer in some families.

Lung-MAP (Lung Cancer Master Protocol) (SWOG S1400)

Lung-MAP is a multi-arm trial designed to test several different therapies simultaneously. MEDI4736, GDC-0032, Palbociclib, and AZD4547 are currently being studied, but the trial protocol could allow new therapies to be added in the future.

LYT-100 in Post-acute COVID-19 Respiratory Disease

To evaluate the safety and efficacy of LYT-100 with post-acute COVID-19 respiratory complications who were treated with, but no longer require mechanical ventilation, extracorporeal membrane oxygenation, non-invasive ventilation (eg CPAP or BiPAP), high-flow nasal oxygen therapy, or combination thereof.



RELIANCE is multi-site pragmatic study to compare long-term roflumilast use with long-term azithromycin use in people who have COPD with chronic bronchitis who have been hospitalized in the past year.

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis.


SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

TRS003 Bevacizumab

A Phase 3, Multicenter, Randomized and Double-Blind Study to Assess the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab in Subjects With Advanced Nonsquamous NSCLC.

Get Your Study Listed

See how your institution or organization can add its study to our lung disease clinical trials listing.

Freedom From Smoking Clinic
, | Oct 25, 2021
Community Connections: Air Quality & Lung Disease
, | Jan 19, 2022